Related Experiment Video
Updated: Feb 27, 2026

16:18
Microfluidic Device for Recreating a Tumor Microenvironment in Vitro
Published on: November 20, 2011
12.1K
Microfluidic device flow field characterization around tumor spheroids with tunable necrosis produced in an optimized
James Baye1, Casey Galvin1, Amy Q Shen2
1Okinawa Institute of Science and Technology Graduate School, 1919-1 Tancha, Onna-son, Okinawa, 904-0495, Japan.
Biomedical Microdevices
|July 2, 2017
Summary
Researchers controlled tumor spheroid properties, including necrotic core formation, using microfluidic devices. This 3-D tumor model advancement aids in evaluating cancer therapies by isolating the impact of necrosis on treatment efficacy.
Area of Science:
- Biomedical Engineering
- Cancer Research
- Microfluidics
Background:
- Tumor spheroids are advanced 3-D in vitro models for cancer research.
- Microfluidic devices offer precise control over spheroid microenvironments.
- Tailoring spheroid properties is crucial for accurate drug efficacy testing.
Purpose of the Study:
- To demonstrate controlled tumor spheroid growth and necrotic core formation.
- To investigate nanoparticle hydrodynamics and mass transport within tumor spheroids.
- To assess the impact of spheroid characteristics on therapy evaluation.
Main Methods:
- Controlled seeding of human colon cancer cells (HCT-116) in microwells.
- Manipulation of glucose concentration to control necrotic core presence.
- Micro-particle imaging velocimetry (micro-PIV) for hydrodynamic analysis.
- Fluorescent nanoparticle tracking to study mass transport.
Main Results:
- Tumor spheroid growth rates were controlled by initial cell seeding density.
- Necrotic core formation was modulated by glucose concentration without altering spheroid size or hypoxia.
- Microfluidic device geometry influenced flow velocity distribution across the spheroid.
- Nanoparticle accumulation and penetration depth were dependent on flow dynamics and particle size.
Conclusions:
- Controlled manipulation of tumor spheroid characteristics, specifically necrotic core presence, is achievable.
- Microfluidic platforms enable detailed analysis of nanoparticle transport within 3-D tumor models.
- This approach enhances the potential for in vitro cancer therapy assessment by isolating key biological factors.

